HYPERA SA (HYPMY) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 28 250 sessions, September 15, 2025 to September 15, 2026
- Largest daily move
- +13.3% close of January 9, 2026
- 1-year change
- +7.3% closing prices, September 15, 2025 to September 15, 2026
- 5-year change
- -29.9% closing prices, September 15, 2021 to September 15, 2026
Company Description
HYPERA SA (OTC: HYPMY) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.9B.
HYPMY has gained 7.3% over the past year. The last closing price was $4.55.
This page collects what Stock Titan holds for HYPMY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HYPERA SA (HYPMY) closed at $4.55 on September 15, 2026. Over the past 12 months, the price has gained 7.3%.
HYPMY Metrics & Rankings
Price returns through September 15, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HYPERA SA has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, acquisition. View all HYPMY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in HYPERA SA (HYPMY) currently stands at 6.2 thousand shares, down 32.9% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has increased by 38806.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for HYPERA SA (HYPMY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.9 days.
HYPMY Company Profile & Sector Positioning
HYPERA SA (HYPMY) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HYPMY often look at related companies in the same sector, including ALMIRALL SA (LBTSF), ALMIRALL SA (ALMRY), SOFGEN PHARMA S.A (PROCF), SUMITOMO PHARMA CO (SMDPY), and HIKMA PHARMS PLC (HKMPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HYPMY's relative position within its industry.